2
Registered trials
1
Recruiting
0
Completed trials
2
Sponsors
1
Countries
Phase II:
2
Indications tested
All trials
2 total-
MELFLUFEN FOR ELDERLY PATIENTS WITH RELAPSED MYELOMA Not authorised
Showing 1–2 of 2 trials